GlassScriptPhysician profile
Marie C Jacques
NPI 1457488082
$844.78
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.98 · 2020: $68.22 · 2021: $154 · 2022: $50.18 · 2023: $72.33 · 2024: $276 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $139.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $128.38 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Lilly USA, LLC | $125.56 | 2020-2023 | Jardiance |
| Sanofi Pasteur INC. | $70.80 | 2021-2024 | |
| Cranial Technologies, INC | $50.07 | 2021-2023 | Doc Band |
| Biomarin Pharmaceutical INC. | $49.81 | 2024 | Voxzogo 1.2mg |
| Alk-Abello, INC | $42.98 | 2024-2025 | Grastek, Ragwitek, Odactra |
| Shield Therapeutics INC | $38.27 | 2023-2024 | Accrufer |
| Abbott Laboratories | $33.79 | 2021-2024 | Freestyle Libre 3 |
| Phadia US INC. | $32.66 | 2025 | Immunocap |
| Cumberland Pharmaceuticals, INC. | $30.14 | 2024 | Kristalose |
| Takeda Pharmaceuticals U.S.A., INC. | $24.02 | 2024 | |
| Alexion Pharmaceuticals, INC. | $23.51 | 2025 | Koselugo |
| Glaxosmithkline, LLC. | $21.35 | 2020 | |
| Chiesi USA, INC. | $19.73 | 2024 | Mycapssa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $13.96 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Jacques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.